IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo article

Scientific Reports

Volumn 6, Issue 1, 2016, Pages

  Kritikou, Joanna S ^a   Dahlberg, Carin I M ^a   Baptista, Marisa A P ^a   Wagner, Arnika K ^a   Banerjee, Pinaki P ^b   Gwalani, Lavesh Amar ^b   Poli, Cecilia ^b   Panda, Sudeepta K ^c   Kärre, Klas ^a   Kaech, Susan M ^d,e   Wermeling, Fredrik ^c   Andersson, John ^c   Orange, Jordan S ^b   Brauner, Hanna ^a   Westerberg, Lisa S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD226 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; NCAM1 PROTEIN, HUMAN; T LYMPHOCYTE ANTIGEN; WISKOTT ALDRICH SYNDROME PROTEIN;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; CYTOTOXICITY; DEFICIENCY; DEGRANULATION; HUMAN; IMMUNOLOGY; LYMPHOMA; METABOLISM; MORTALITY; NATURAL KILLER CELL; PATHOLOGY; SECRETION (PROCESS); SURVIVAL ANALYSIS; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTINEOPLASTIC AGENTS; CD56 ANTIGEN; CELL DEGRANULATION; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOMA; MICE, INBRED BALB C; MICE, INBRED C57BL; SURVIVAL ANALYSIS; TUMOR MICROENVIRONMENT; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 85015669882     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30636     Document Type: Article

References (53)

1. Raulet, D. H. & Vance, R. E. Self-tolerance of natural killer cells. Nat Rev Immunol 6, 520-531 (2006).
2. Lanier, L. L. Missing self, NK cells, and The White Album. J Immunol 174, 6565 (2005).
3. Vivier, E., Ugolini, S., Blaise, D., Chabannon, C. & Brossay, L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12, 239-252 (2012).
4. Parham, P. & Moffett, A. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13, 133-144 (2013).
5. Sun, J. C. & Lanier, L. L. NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol 11, 645-657 (2011).
6. Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678 (1986).
7. Brodin, P., Lakshmikanth, T., Johansson, S., Karre, K. & Hoglund, P. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 113, 2434-2441 (2009).
8. Fernandez, N. C. et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self- MHC molecules. Blood 105, 4416-4423 (2005).
9. Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713 (2005).
10. Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15, 486-499 (2015).
11. Grosso, J. F. et al. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems. J Clin Invest 117, 3383-3392 (2007).
12. Li, Y. et al. Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition. Immunity 31, 35-46 (2009).
13. Jonjic, S. Functional plasticity and robustness are essential characteristics of biological systems: lessons learned from KLRG1- deficient mice. Eur J Immunol 40, 1241-1243 (2010).
14. Malaise, M. et al. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma. J Immunol 192, 1954-1961 (2014).
15. Lagrue, K. et al. The central role of the cytoskeleton in mechanisms and functions of the NK cell immune synapse. Immunol Rev 256, 203-221 (2013).
16. Huang, W., Ochs, H. D., Dupont, B. & Vyas, Y. M. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement. J Immunol 174, 2602-2611 (2005).
17. Orange, J. S. et al. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J Clin Invest 121, 1535-1548, (2011).
18. Senapati, J. et al. Diffuse large B cell lymphoma in wiskott-Aldrich syndrome: a case report and review of literature. Indian journal of hematology & blood transfusion: an official journal of Indian Society of Hematology and Blood Transfusion 30, 309-313 (2014).
19. Du, S. et al. Hodgkin's and non-Hodgkin's lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatric and developmental pathology: the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 14, 64-70 (2011).
20. Sullivan, K. E., Mullen, C. A., Blaese, R. M. & Winkelstein, J. A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125, 876-885 (1994).
21. Filipovich, A. H., Mathur, A., Kamat, D. & Shapiro, R. S. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 52, 5465s-5467s (1992).
22. Salavoura, K., Kolialexi, A., Tsangaris, G. & Mavrou, A. Development of cancer in patients with primary immunodeficiencies. Anticancer Res 28, 1263-1269 (2008).
23. Catucci, M. et al. Wiskott-Aldrich syndrome protein deficiency in natural killer and dendritic cells affects antitumor immunity. Eur J Immunol 44, 1039-1045 (2014).
24. Ishihara, D. et al. Wiskott-Aldrich syndrome protein regulates leukocyte-dependent breast cancer metastasis. Cell reports 4, 429-436 (2013).
25. Gismondi, A. et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood 104, 436-443 (2004).
26. Fathman, J. W. et al. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. Blood 118, 5439-5447 (2011).
27. Johansson, S. et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 201, 1145-1155 (2005).
28. Shibuya, K. et al. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J Exp Med 198, 1829-1839 (2003).
29. Gordon, S. M. et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36, 55-67 (2012).
30. Kalia, V., Penny, L. A., Yuzefpolskiy, Y., Baumann, F. M. & Sarkar, S. Quiescence of Memory CD8(+) T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4. Immunity 42, 1116-1129 (2015).
31. Orange, J. S. et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cellactivating immunologic synapses. Proc Natl Acad Sci USA 99, 11351-11356 (2002).
32. Castriconi, R. et al. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res 64, 9180-9184 (2004).
33. Ma, Y., Aymeric, L., Locher, C., Kroemer, G. & Zitvogel, L. The dendritic cell-tumor cross-talk in cancer. Curr Opin Immunol 23, 146-152 (2011).
34. Ozcan, E., Notarangelo, L. D. & Geha, R. S. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 122, 1054-1062 (2008).
35. Guia, S. et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal 4, ra21 (2011).
36. Pageon, S. V. et al. Superresolution microscopy reveals nanometer-scale reorganization of inhibitory natural killer cell receptors upon activation of NKG2D. Sci Signal 6, ra62 (2013).
37. Cotta-de-Almeida, V. et al. Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development. Proc Natl Acad Sci USA 104, 15424-15429 (2007).
38. Westerberg, L. S. et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. Blood 119, 3966-3974 (2012).
39. Bjorkstrom, N. K., Ljunggren, H. G. & Sandberg, J. K. CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends in immunology 31, 401-406 (2010).
40. Nabekura, T. et al. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 40, 225-234 (2014).
41. Martinet, L. et al. DNAM-1 expression marks an alternative program of NK cell maturation. Cell reports 11, 85-97 (2015).
42. Seth, S. et al. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. J Leukoc Biol 86, 91-101 (2009).
43. Bottino, C. et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198, 557-567 (2003).
44. Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295 (2007).
45. Levin, A. M. et al. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature 484, 529-533 (2012).
46. Ardolino, M. et al. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J Clin Invest 124, 4781-4794 (2014).
47. Joncker, N. T., Shifrin, N., Delebecque, F. & Raulet, D. H. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 207, 2065-2072 (2010).
48. Wagner, A. K. et al. Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response. Cancer immunology research 4, 113-123 (2016).
49. Roy-Ghanta, S. & Orange, J. S. Use of cytokine therapy in primary immunodeficiency. Clin Rev Allergy Immunol 38, 39-53 (2010).
50. Iannello, A., Thompson, T. W., Ardolino, M., Marcus, A. & Raulet, D. H. Immunosurveillance and immunotherapy of tumors by innate immune cells. Curr Opin Immunol 38, 52-58 (2016).
51. Sutlu, T. & Alici, E. Natural killer cell-based immunotherapy in cancer: current insights and future prospects. Journal of internal medicine 266, 154-181 (2009).
52. Lutskiy, M. I., Rosen, F. S. & Remold-O'Donnell, E. Genotype-proteotype linkage in the Wiskott-Aldrich syndrome. J Immunol 175, 1329-1336 (2005).
53. Wickstrom, S. L., Oberg, L., Karre, K. & Johansson, M. H. A genetic defect in mice that impairs missing self recognition despite evidence for normal maturation and MHC class I-dependent education of NK cells. J Immunol 192, 1577-1586 (2014).